Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,071 INR | +3.52% | +1.03% | +25.41% |
Sales 2024 * | 121B 1.46B | Sales 2025 * | 140B 1.69B | Capitalization | 292B 3.51B |
---|---|---|---|---|---|
Net income 2024 * | 33.36B 401M | Net income 2025 * | 11.13B 134M | EV / Sales 2024 * | 2.57 x |
Net Debt 2024 * | 19.84B 238M | Net cash position 2025 * | 3.08B 36.99M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
40.8
x | P/E ratio 2025 * |
24
x | Employees | 15,556 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.27% | Free-Float | 49.03% |
Latest transcript on Glenmark Pharmaceuticals Limited
1 day | +2.55% | ||
1 week | +1.83% | ||
Current month | +10.69% | ||
1 month | +10.83% | ||
3 months | +19.18% | ||
6 months | +41.30% | ||
Current year | +24.23% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Chief Executive Officer | 54 | 98-10-11 | |
Ulhas Dhuppad
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-13 | |
Cherylann Pinto
BRD | Director/Board Member | 56 | 99-10-05 |
Chief Executive Officer | 54 | 98-10-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1,071 | +3.52% | 657 378 |
24-04-23 | 1,034 | -0.47% | 1,223,564 |
24-04-22 | 1,039 | +1.26% | 260,452 |
24-04-19 | 1,026 | -1.48% | 762,705 |
24-04-18 | 1,042 | -1.72% | 1,139,829 |
Delayed Quote NSE India S.E., April 24, 2024 at 03:21 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.23% | 3.5B | |
+18.33% | 42.77B | |
+20.21% | 22.23B | |
+13.67% | 14.44B | |
+11.28% | 13.05B | |
+35.95% | 11.59B | |
-8.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+5.03% | 4.97B |
- Stock Market
- Equities
- GLENMARK Stock